RSS Feed For (NASDAQ:CRXL)

CRUCELL SP.ADR (NASDAQ:CRXL)

21.62 +0.17 (0.79%)
CRUCELL SP.ADR (NASDAQ:CRXL) Delayed :
Previous Close $21.45    52 Week High $25.53 
Open $21.40    52 Week Low $11.29 
Day High $21.71    P/E N/A 
Day Low $21.36    EPS $0.00 
Volume 77,929       
More CRXL Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
WYE 15 PFE 13
JNJ 7 ARM 6
ASR 6 CAT 6
WAG 6 GE 6
FDX 5 XE 5
CELL 5 HOT 5
View All Friends, Peers and Foes

StreetInsider Reports on CRXL by Category

View All FilingsSEC Filings on CRXL

Nov 16, 2009 06:32AM Form 6-K CRUCELL NV For: Nov 16
Nov 4, 2009 08:36AM Form 6-K CRUCELL NV For: Nov 03
Oct 27, 2009 08:12AM Form 6-K CRUCELL NV For: Oct 27
Oct 21, 2009 11:02AM Form 6-K CRUCELL NV For: Oct 21
Oct 20, 2009 04:28PM Form 6-K CRUCELL NV For: Oct 20
View All Filings

View All Comments Comments on recent CRXL articles

relaxed137
on Jun 14, 2009
at 05:38 PM
ASFX has a swine flu product ASFX.pk sells the thermofocus at walgreens and babies-r-us. It's a no-touch thermometer and orders are going through the roof. Buy one for yourself so you can take temperatures with out getting the swine flu! http://finance.yahoo.com/news/Safety-Product-Company-Sees-prnews-15504232.html?.v=1 This thermometer (Thermofocus) was used heavily in ASIA during SARS
Article: Swine Flu Stock Rundown
Tony C
on Apr 28, 2009
at 09:13 AM
money makers that will save- prolong life provectus pharma pvct another cancer cure +++ dandrion DNDN jump on board
Article: U.S. Issues Public Health Emergency About Swine Flu
Peter
on Apr 27, 2009
at 10:51 PM
3M's New Flu Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: Swine Flu Stock Rundown
natalia
on Apr 27, 2009
at 10:40 PM
i see what you mean that stock finished up over 18% for the day on big volume. that's a much bigger gain than most of those stocks mentioned by hot list - and it was much higher earlier in the day. http://cxa.marketwatch.com/tsx/en/market/quote.aspx?symbol=rbm
Article: U.S. Issues Public Health Emergency About Swine Flu
Peter H
on Apr 27, 2009
at 10:16 PM
3M Rapid Detection Flu A+B Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: U.S. Issues Public Health Emergency About Swine Flu
View All Comments

Comments on CRXL


No comments are currently available.